Limba
|
MYLS22 is a first-in-class and selective inhibitor of optic atrophy 1 (OPA1)with anti-angiogenesis and anti-cancer activity.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
MYLS22 is a first-in-class and selective inhibitor of optic atrophy 1 (OPA1)with anti-angiogenesis and anti-cancer activity. |